Features and Benefits of Ultimedex via CKO7
o
o
o
o
Supports integrated medication management with the following UltiMedex clinical
modules:
 Medication Advisory Screening, Patient Specific Dosing V2 and IV Compatibility
Screening
 Clinical decision support in DrugPoints w/Links to DrugDex and the Images and
Imprints database
 Referential Content for Consumers included in DrugNotes™ (English & Spanish)
and Warning Labels
 RED BOOK™- Drug Products & Pricing Data (RxNorm and NDC coverage)
Supports Meaningful use requirements for drug/drug and drug/allergy interaction
screening; maintenance of medication lists and for e-prescribing using RED BOOK data
More up to date and robust patient specific dosing:
 Includes Renal and hepatic adjustments
 Includes FDA approved indication based dosing using ICD9 and SNOMED codes
for FDA labeled uses
 Supports larger quantity of drugs (both single and combination ingredient;
chemo and Narrow Therapeutic Index(NTI)
 Updated for new drugs being introduced to the market
Flexible development environment simplifies integration for vendor partners:
 CKO service can be accessed either directly through XML Post or a .NET client
side library
 Available through 2 delivery methods:
1. Hosted – remote web-service
2. Client Server Platform – (Windows and Linux)
 Customers are able to configure according to their needs by selecting modules
of interest to their users and establishing screening filter levels
UltiMedex Products Impacted
There are several products bundled in UltiMedex, and we are not retiring the individual
products overall, only the method by which some data can be received. Following is a matrix
outlining product availability:
Product
Delivery Format Availability
Medication Advisory Screening
CKO7
Available
Patient Specific Dosing Version 2
Available
DrugPoints
Available
ASCII/Flat files
Not Available
beginning
1/1/2014*
Not Available
beginning
1/1/2014*
Available
DrugNotes
Available
Available
Warning labels
Available
Available
Images and Imprints
Available
Available
IV Screening
Available
Not Available
beginning
1/1/2014*
*Note for MEDITECH customers:
There is no impact on your
Formulary Services solution while
MEDITECH works to incorporate
CKO7. While the exact timing of
availability of clinical screening
using Ultimedex CKO7 is not yet
known, we anticipate that it will
begin within the next 12 months.
We expect to have an
announcement on this effort in
Quarter two, 2013.
Note that the following are being retired and will no longer be available for implementation.
Dose 10/90
Patient Specific Dosing V1
CKO6.14